Therapeutic Challenges in the Use of Chemotherapy and Cyclin-Dependent Kinase 4/6 Inhibitors in a Patient With Charcot-Marie-Tooth Disease and Breast Cancer
Year: 2025
Type: article
Study design: Case Report
Abstract: We report a rare clinical scenario involving a 65-year-old female patient with Charcot-Marie-Tooth (CMT) disease who was diagnosed with early-stage breast carcinoma. The patient underwent neoadjuvant chemotherapy, followed by surgery and adjuvant endocrine therapy. During treatment, she developed grade 3 peripheral neuropathy, leading to the early discontinuation of paclitaxel and subsequent therapeutic adjustments. This report highlights the challenges of managing patients with neuromuscular comorbidities undergoing chemotherapy and the use of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors as adjuvant therapy in breast cancer treatment.
Source: Cureus
DOI: 10.7759/cureus.90239
Authors: Pedro Mota Araújo, Renato Cunha, Marta Sousa
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4413452314
